← Back to Analyst Consensus 
BIIB Buy
BIOGEN INC.
Current Price —
Implied Upside —
Analysts 43
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 5 reiterations from 6 firms
Next Earnings
Oct 28, 2026 (1 day)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 22, 2026 | B of A Securities | maintain | Neutral → Neutral | $244 | 53% |
| Oct 21, 2026 | TD Cowen | maintain | Buy → Buy | $250 | 54% |
| Oct 20, 2026 | Wells Fargo | maintain | Overweight → Overweight | $310 | 54% |
| Oct 12, 2026 | JP Morgan | upgrade | Neutral → Overweight | $300 | 55% |
| Oct 9, 2026 | UBS | maintain | Buy → Buy | $270 | 54% |
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | $256 | 55% |
| Sep 10, 2026 | HSBC | maintain | Reduce → Reduce | $175 | 52% |
| Sep 3, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $245 | 54% |
| Aug 25, 2026 | RBC Capital | maintain | Outperform → Outperform | $260 | 55% |
| Aug 13, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | $300 | 54% |
| Aug 4, 2026 | Mizuho | maintain | Outperform → Outperform | $241 | 52% |
| Aug 3, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jul 30, 2026 | UBS | maintain | Buy → Buy | $240 | 54% |
| Jul 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $251 | 44% |
| Jul 30, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $231 | 54% |
| Jul 30, 2026 | RBC Capital | maintain | Outperform → Outperform | $240 | 55% |
| Jul 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | $248 | 48% |
| Jul 30, 2026 | TD Cowen | maintain | Buy → Buy | $225 | 54% |
| Jul 30, 2026 | Wedbush | maintain | Neutral → Neutral | $215 | 57% |
| Jul 29, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | $200 | 53% |
| Jul 21, 2026 | Guggenheim | maintain | Buy → Buy | $280 | 52% |
| Jul 21, 2026 | B of A Securities | maintain | Neutral → Neutral | $215 | 53% |
| Jul 13, 2026 | Truist Securities | upgrade | Hold → Buy | $235 | 54% |
| Jul 8, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 7, 2026 | RBC Capital | maintain | Outperform → Outperform | $242 | 55% |
| Jun 29, 2026 | Needham | maintain | Buy → Buy | $256 | 50% |
| Jun 18, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $224 | 54% |
| Jun 15, 2026 | Mizuho | maintain | Outperform → Outperform | $221 | 52% |
| Jun 8, 2026 | Needham | upgrade | Hold → Buy | $255 | 50% |
| May 27, 2026 | RBC Capital | maintain | Outperform → Outperform | $227 | 55% |
| May 15, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $225 | 54% |
| May 1, 2026 | Citigroup | maintain | Neutral → Neutral | $200 | 54% |
| Apr 30, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $206 | 54% |
| Apr 30, 2026 | RBC Capital | maintain | Outperform → Outperform | $222 | 55% |
| Apr 30, 2026 | Guggenheim | maintain | Buy → Buy | $260 | 52% |
| Apr 30, 2026 | Wedbush | maintain | Neutral → Neutral | $196 | 57% |
| Apr 22, 2026 | UBS | upgrade | Neutral → Buy | $225 | 54% |
| Apr 20, 2026 | Wells Fargo | upgrade | Equal-Weight → Overweight | $250 | 54% |
| Apr 14, 2026 | Piper Sandler | upgrade | Neutral → Overweight | $214 | 54% |
| Apr 13, 2026 | Citigroup | maintain | Neutral → Neutral | $190 | 54% |
| Apr 13, 2026 | Truist Securities | maintain | Hold → Hold | $189 | 54% |
| Apr 10, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $200 | 54% |
| Apr 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $237 | 44% |
| Apr 1, 2026 | Canaccord Genuity | maintain | Buy → Buy | $245 | 48% |
| Apr 1, 2026 | Oppenheimer | maintain | Outperform → Outperform | $275 | 52% |
| Mar 17, 2026 | HSBC | maintain | Reduce → Reduce | $150 | 52% |
| Feb 23, 2026 | Freedom Broker | maintain | Hold → Hold | $185 | 60% |
| Feb 20, 2026 | Barclays | initiate | — → Equal-Weight | $185 | 53% |
| Feb 10, 2026 | Wedbush | maintain | Neutral → Neutral | $187 | 57% |
| Feb 9, 2026 | JP Morgan | maintain | Neutral → Neutral | $230 | 55% |
Price Target Trend
Aug 24, 2026 Oct 27, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days